These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 10937467)

  • 1. Juvenile myasthenia: diagnosis and treatment.
    Anlar B
    Paediatr Drugs; 2000; 2(3):161-9. PubMed ID: 10937467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Myasthenia gravis: diagnosis and treatment].
    Suárez GA
    Rev Neurol; 1999 Jul 16-31; 29(2):162-5. PubMed ID: 10528332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric Myasthenia Gravis.
    Peragallo JH
    Semin Pediatr Neurol; 2017 May; 24(2):116-121. PubMed ID: 28941526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of myasthenia gravis.
    Arora Y; Li Y
    Hosp Pract (1995); 2013; 41(4):40-50. PubMed ID: 24145588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myasthenia gravis in Hong Kong Chinese. 2. Paediatric disease.
    Wong V; Hawkins BR; Yu YL
    Acta Neurol Scand; 1992 Jul; 86(1):68-72. PubMed ID: 1519477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic strategies for myasthenia gravis.
    Keys PA; Blume RP
    DICP; 1991 Oct; 25(10):1101-8. PubMed ID: 1803801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic options in autoimmune myasthenia gravis.
    García-Carrasco M; Escárcega RO; Fuentes-Alexandro S; Riebeling C; Cervera R
    Autoimmun Rev; 2007 Jun; 6(6):373-8. PubMed ID: 17537383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of myasthenia gravis.
    Schwendimann RN; Burton E; Minagar A
    Am J Ther; 2005; 12(3):262-8. PubMed ID: 15891271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myasthenia Gravis and Congenital Myasthenic Syndromes.
    Ciafaloni E
    Continuum (Minneap Minn); 2019 Dec; 25(6):1767-1784. PubMed ID: 31794470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A practical guide to the recognition and management of myasthenia gravis.
    Evoli A; Batocchi AP; Tonali P
    Drugs; 1996 Nov; 52(5):662-70. PubMed ID: 9118816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune myasthenia gravis, immunotherapy and thymectomy in children.
    Ware TL; Ryan MM; Kornberg AJ
    Neuromuscul Disord; 2012 Feb; 22(2):118-21. PubMed ID: 21911294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Peripheral nervous system immunological disorder].
    Erazo Torricelli R
    Medicina (B Aires); 2018; 78 Suppl 2():82-87. PubMed ID: 30199371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Juvenile myasthenia gravis in Norway: Clinical characteristics, treatment, and long-term outcome in a nationwide population-based cohort.
    Popperud TH; Boldingh MI; Rasmussen M; Kerty E
    Eur J Paediatr Neurol; 2017 Sep; 21(5):707-714. PubMed ID: 28457757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Essentials in the management of myasthenia gravis.
    Galdi AP
    Am Fam Physician; 1978 Jun; 17(6):95-102. PubMed ID: 655080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myasthenia gravis: pathogenesis, diagnosis, and therapy.
    Winkler LH; Winkler GF
    Postgrad Med; 1979 Aug; 66(2):50-6, 59-63. PubMed ID: 450830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myasthenia gravis: signs, symptoms, diagnosis, immunology, and current therapy.
    Scheife RT; Hills JR; Munsat TL
    Pharmacotherapy; 1981; 1(1):39-54. PubMed ID: 6927602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myasthenia gravis. Pathogenesis and current concepts in management.
    Havard CW; Scadding GK
    Drugs; 1983 Aug; 26(2):174-84. PubMed ID: 6884241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidisciplinary treatment for prepubertal juvenile myasthenia gravis with crisis.
    Hirata Y; Inoue M; Nabatame S; Okumura M; Ozono K
    Pediatr Int; 2016 Aug; 58(8):772-4. PubMed ID: 27324449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.
    Evoli A; Tonali PA; Padua L; Monaco ML; Scuderi F; Batocchi AP; Marino M; Bartoccioni E
    Brain; 2003 Oct; 126(Pt 10):2304-11. PubMed ID: 12821509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myasthenia gravis: clinical features, pathogenesis, evaluation, and medical management.
    Heitmiller RF
    Semin Thorac Cardiovasc Surg; 1999 Jan; 11(1):41-6. PubMed ID: 9930711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.